pubmed-article:11464141 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0681867 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0030946 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0132326 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C1136321 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C1522577 | lld:lifeskim |
pubmed-article:11464141 | lifeskim:mentions | umls-concept:C0023981 | lld:lifeskim |
pubmed-article:11464141 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:11464141 | pubmed:dateCreated | 2001-7-20 | lld:pubmed |
pubmed-article:11464141 | pubmed:abstractText | Simpler and less toxic antiretroviral strategies are needed to maximize treatment compliance without sacrificing potency, at least for drug-experienced HIV-infected patients currently on regimens containing protease inhibitors (PIs). Small nonrandomized studies have suggested a beneficial role of PI-sparing regimens on lipodystrophy. | lld:pubmed |
pubmed-article:11464141 | pubmed:language | eng | lld:pubmed |
pubmed-article:11464141 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11464141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11464141 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11464141 | pubmed:month | Jul | lld:pubmed |
pubmed-article:11464141 | pubmed:issn | 1525-4135 | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:LangeJJ | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:RomeuJJ | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:ClotetBB | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:JohnstonSS | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:RuizLL | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:ParedesRR | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:FrancisSS | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:DomingoPP | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:GenMM | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:BalaguéMM | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:NegredoEE | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:BonjochAA | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:FumazC RCR | lld:pubmed |
pubmed-article:11464141 | pubmed:author | pubmed-author:Spanish... | lld:pubmed |
pubmed-article:11464141 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11464141 | pubmed:day | 1 | lld:pubmed |
pubmed-article:11464141 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:11464141 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11464141 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11464141 | pubmed:pagination | 229-36 | lld:pubmed |
pubmed-article:11464141 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:meshHeading | pubmed-meshheading:11464141... | lld:pubmed |
pubmed-article:11464141 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11464141 | pubmed:articleTitle | Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study. | lld:pubmed |
pubmed-article:11464141 | pubmed:affiliation | "IrsiCaixa" Foundation, Retrovirology Laboratory and HIV Unit, Hospital Universitari Germans Trias i Pujol, Badalona, Spain. lruiz@ns.hugtip.scs.es | lld:pubmed |
pubmed-article:11464141 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11464141 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11464141 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:11464141 | pubmed:publicationType | Multicenter Study | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11464141 | lld:pubmed |